Publication | Closed Access
Clinical and immunological outcomes of high- and low-dose rituximab treatments in patients with pemphigus: a randomized, comparative, observer-blinded study
104
Citations
24
References
2014
Year
A few clinical and immunological study parameters have suggested improved outcomes in patients receiving high-dose (2 × 1000 mg) rituximab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1